Status:
WITHDRAWN
A Novel Magnetic Needle Using Iron Oxide Nanoparticles for the Detection of Leukemia
Lead Sponsor:
University of New Mexico
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Leukemia
Eligibility:
All Genders
Phase:
NA
Brief Summary
The purpose of this study is to determine if the magnetic needle, in combination with magnetic nanoparticles can accurately identify minimal residual disease in leukemia patients.
Detailed Description
The ability to reliably detect Minimal Residual Disease (MRD) in leukemia patients allows oncologists to predict patient outcome and to monitor the efficacy of therapy which is critical to improving c...
Eligibility Criteria
Inclusion
- Group: Leukemia Patients
- Suspected diagnosis of Leukemia
- Requiring bone marrow biopsy for standard care
Exclusion
- unable to consent for entrance into the study
- Group: Non-leukemia Patients
- Inclusion Criteria:
- Requiring bone marrow biopsy for standard care
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01411904
Start Date
August 1 2010
End Date
December 1 2013
Last Update
December 11 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of New Mexico Health Sciences Center
Albuquerque, New Mexico, United States, 87131